News
AUA 2024, Non–muscle-Invasive Bladder Cancer (NMIBC), TAR-210, erdafitinib, MoonRISe-1 study, FGFR Alterations, tyrosine kinase inhibitor, gemcitabine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback